C
Ultralife Corporation ULBI
$4.13 -$0.15-3.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -10.56% 118.54% 296.37% 3,602.69% 6,121.85%
Total Depreciation and Amortization 6.29% -1.03% -4.70% -8.82% -12.29%
Total Amortization of Deferred Charges 42.19% 1.69% 25.49% 42.22% 77.78%
Total Other Non-Cash Items 14.38% 25.30% 135.18% 1,409.05% 1,078.07%
Change in Net Operating Assets 135.21% 113.62% -15.84% -336.63% -102.51%
Cash from Operations 762.42% 677.39% 311.69% 440.91% 252.73%
Capital Expenditure 24.29% -27.38% -7.78% -34.46% -52.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -1,857.45% -27.38% -7.78% -34.46% -52.00%
Total Debt Issued 658.62% -84.00% -51.64% 17.86% 116.42%
Total Debt Repaid -758.23% -540.40% -422.63% 0.00% -5.89%
Issuance of Common Stock 60.18% 108.17% 4,703.08% 64,333.33% 975.86%
Repurchase of Common Stock -- -100.00% -100.00% 0.00% 46.67%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 9.33% -- -- --
Cash from Financing 443.90% -482.74% -411.57% 253.88% 959.85%
Foreign Exchange rate Adjustments 111.26% 49.74% 71.77% 49.24% -9.42%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -175.01% -159.46% -150.27% 1,109.89% 269.07%